What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?

被引：2
|
作者：
Phillips, Ryan [1 ]
Ost, Piet [2 ]
Tran, Phuoc T. [1 ,3 ,4 ]
机构：
[1] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA
[2] Univ Ghent, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium
[3] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Dept Urol, Baltimore, MD 21218 USA
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 24期
关键词：
castration-resistant prostate cancer; neoplasm metastasis; neoplasm recurrence; oligometastasis; prostate cancer; stereotactic ablative radiotherapy; stereotactic body radiation therapy; ANDROGEN DEPRIVATION; BODY RADIOTHERAPY; LUNG-CANCER; THERAPY; HISTORY;
D O I：
10.2217/fon-2017-0337
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2121 / 2124
页数：4
相关论文
共 50 条
  • [1] Complete PSA Response Following Stereotactic Ablative Radiotherapy for a Bony Metastasis in the Setting of Castrate-Resistant Prostate Cancer
    Lukovic, Jelena
    Rodrigues, George
    [J]. CUREUS, 2015, 7 (10):
  • [2] Stereotactic ablative body radiotherapy for oligometastatic inguinal lymph node in castrate resistant prostate cancer
    Goyal, Shikha
    Periasamy, Kannan
    Madan, Renu
    Vias, Poorva
    Chandran, Vigneshwaran
    [J]. ASIAN JOURNAL OF UROLOGY, 2023, 10 (01) : 109 - 112
  • [3] Recomendations on the Management of Controversies in Advanced Castrate-Resistant Prostate Cancer
    Cozar, J. M.
    Solsona, E.
    Morote, J.
    Minana, B.
    Maroto, J. P.
    Gonzalez del Alba, A.
    Climent, M. A.
    Carles, J.
    Alcaraz, A.
    Castellano, D.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (10): : 569 - 577
  • [4] Treatment of castrate-resistant prostate cancer - What is the best management?
    Uemura, Hirotsugu
    Reiter, Robert
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (04) : 427 - 427
  • [5] Castrate-Resistant Prostate Cancer Foreword
    Taneja, Samir S.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : XIII - XIII
  • [6] Metastatic castrate-resistant prostate cancer
    Schellhammer, Paul
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 51 - 52
  • [7] Castrate-Resistant Prostate Cancer Preface
    Kibel, Adam S.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : XV - XV
  • [8] Treatment of Castrate-Resistant Prostate Cancer
    Logothetis, Christopher J.
    [J]. JOURNAL OF UROLOGY, 2013, 190 (02): : 439 - 440
  • [9] Potential role of rituximab in metastatic castrate-resistant prostate cancer
    Bindal, Poorva
    Jalil, Sharif A. A.
    Holle, Lisa M.
    Clement, Jessica M.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1509 - 1511
  • [10] Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer
    Hannan, Raquibul
    Dohopolski, Michael J.
    Pop, Laurentiu M.
    Mannala, Samantha
    Watumull, Lori
    Mathews, Dana
    Gao, Ang
    Garant, Aurelie
    Arriaga, Yull E.
    Bowman, Isaac
    Chung, Jin-Sung
    Wang, Jing
    Ariizumi, Kiyoshi
    Ahn, Chul
    Timmerman, Robert
    Courtney, Kevin
    [J]. BIOMEDICINES, 2022, 10 (06)
12345